JP Patent

JP5823383B2 — 長時間作用性のムスカリン拮抗剤および長時間作用性のβ2アドレナリン受容体作動剤を肺送達するための組成物ならびに関連の方法および系

Assigned to パール セラピューティクス,インコーポレイテッド · Expires 2015-11-25 · 10y expired

What this patent protects

Patent listed against null.

Drugs covered by this patent

Patent Metadata

Patent number
JP5823383B2
Jurisdiction
JP
Classification
Expires
2015-11-25
Drug substance claim
No
Drug product claim
No
Assignee
パール セラピューティクス,インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.